Talk:Adenocarcinoma of the lung: Difference between revisions

Content deleted Content added

Inline

Revision as of 04:17, 16 January 2017

Medicine: Hematology-oncology / Pathology / Pulmonology C‑class High‑importance

	Medicine portal This article is within the scope of WikiProject Medicine, which recommends that medicine-related articles follow the Manual of Style for medicine-related articles and that biomedical information in any article use high-quality medical sources. Please visit the project page for details or ask questions at Wikipedia talk:WikiProject Medicine.MedicineWikipedia:WikiProject MedicineTemplate:WikiProject Medicinemedicine articles
C	This article has been rated as C-class on Wikipedia's content assessment scale.
High	This article has been rated as High-importance on the project's importance scale.
	This article is supported by the Hematology-oncology task force.
	This article is supported by the Pathology task force.
	This article is supported by the Pulmonology task force.

Reading

Reading this page was painful. First, it repeats the same facts as if repeating them multiple times will legitimize the article. As a result it is confusing. Furthermore, it appears to have been written by two people with different voices and it stutters between unrelated sentences. It is like someone came in and added the fact about this being the most common cancer in non-smokers haphazardly. It needs a rewrite and more information. Additional information would either be a link to cancer treatments or details on specific complications and treatments for this type of cancer. For example, it often ends up wrapping around the primary vein in the lungs, causing head and hand swelling. Luckily, it is slow growing and slow spreading, so someone can have it for years.

More details, less repetition, please. Maztec (talk) 21:23, 21 July 2010 (UTC)[reply]

Classification > Redundancy with "lung cancer"

Lung cancer is an extremely heterogeneous family of malignant neoplasms,^[1] with over 50 different histological variants recognized in the 4th revision of the World Health Organization (WHO) typing system, currently the most widely used lung cancer classification scheme.^[2] Because these variants have differing genetic, biological, and clinical properties, including response to treatment, correct classification of lung cancer cases are necessary to assure that lung cancer patients receive optimum management.^[3]^[4] While a small percentage of lung cancers are mainly sarcoma or tumors of hematopoietic or germ cell origin,^[5] approximately 98% of lung cancers are carcinoma, which are tumors composed of cells with epithelial characteristics.^[5] Adenocarcinomas (AdC's) are one of 8 major groups of lung carcinomas recognized in WHO-2004:^[2]

Squamous Cell Carcinoma
Small Cell Carcinoma
Adenocarcinoma
Large Cell Carcinoma
Adenosquamous Carcinoma
Sarcomatoid Carcinoma
Carcinoid Tumor
Salivary Gland-like Carcinoma

^ Roggli VL, Vollmer RT, Greenberg SD, McGavran MH, Spjut HJ, Yesner R (June 1985). "Lung cancer heterogeneity: a blinded and randomized study of 100 consecutive cases". Hum. Pathol. 16 (6): 569–79. doi:10.1016/S0046-8177(85)80106-4. PMID 2987102.{{cite journal}}: CS1 maint: multiple names: authors list (link)
^ ^a ^b Cite error: The named reference who2004 was invoked but never defined (see the help page).
^ Rossi G, Marchioni A, Sartori1 G, Longo L, Piccinini S, Cavazza A (2007). "Histotype in non-small cell lung cancer therapy and staging: The emerging role of an old and underrated factor". Curr Resp Med Rev. 3: 69–77. doi:10.2174/157339807779941820.{{cite journal}}: CS1 maint: multiple names: authors list (link) CS1 maint: numeric names: authors list (link)
^ Vincent MD (August 2009). "Optimizing the management of advanced non-small-cell lung cancer: a personal view". Curr Oncol. 16 (4): 9–21. doi:10.3747/co.v16i4.465. PMC 2722061. PMID 19672420.
^ ^a ^b Cite error: The named reference Travis95 was invoked but never defined (see the help page).

[RoggliVollmer-1] Roggli VL, Vollmer RT, Greenberg SD, McGavran MH, Spjut HJ, Yesner R (June 1985). "Lung cancer heterogeneity: a blinded and randomized study of 100 consecutive cases". Hum. Pathol. 16 (6): 569–79. doi:10.1016/S0046-8177(85)80106-4. PMID 2987102.{{cite journal}}: CS1 maint: multiple names: authors list (link)

[who2004-2] Cite error: The named reference who2004 was invoked but never defined (see the help page).

[RossiMarchioni-3] Rossi G, Marchioni A, Sartori1 G, Longo L, Piccinini S, Cavazza A (2007). "Histotype in non-small cell lung cancer therapy and staging: The emerging role of an old and underrated factor". Curr Resp Med Rev. 3: 69–77. doi:10.2174/157339807779941820.{{cite journal}}: CS1 maint: multiple names: authors list (link) CS1 maint: numeric names: authors list (link)

[Vincent-4] Vincent MD (August 2009). "Optimizing the management of advanced non-small-cell lung cancer: a personal view". Curr Oncol. 16 (4): 9–21. doi:10.3747/co.v16i4.465. PMC 2722061. PMID 19672420.

[Travis95-5] Cite error: The named reference Travis95 was invoked but never defined (see the help page).

[1]

[2]

[3]

[4]

[5]

@@ Line 19: / Line 19: @@
 *Carcinoid Tumor
 *Salivary Gland-like Carcinoma
-Removed > Redundancy with "lung cancer" [[User:Patho|patho]] ([[User talk:Patho|talk]]) 13:05, 25 February 2014 (UTC)